After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Truist Financial analyst Richard Newitter maintained a Hold rating on Medtronic (MDT – Research Report) on February 23 and set a price target ...
Medtronic plc, a global leader in healthcare technology, announced that Medtronic Malaysia and Malaysian Society of Colorectal Surgeons (MSCRS) have signed a Memorandum of Understanding (MoU) to ...
Medtronic USA Inc.'s argument that its implantable heart monitors are “medicines” exempt from sales tax seemed to divide two justices on a California appeals court panel at oral arguments Monday.
The FDA approved adaptive deep brain stimulation (DBS) technology (BrainSense adaptive DBS and BrainSense electrode ...
Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...
There is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
The closed-loop system dynamically self-adjusts DBS therapy to individual brain activity in real time, providing personalized ...
First Selectman Michael Freda said he's working with Medtronics to improve the area around its North Haven site though the ...
The BrainSense Adaptive technology is an enhancement to Medtronic’s Percept DBS neurostimulators. The advancement personalizes therapy based on a patient’s brain activity in real-time. Therapy ...
The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results